Lv2
140 积分 2024-07-16 加入
Trastuzumab Rezetecan in Human Epidermal Growth Factor Receptor 2–Expressing Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma and Colorectal Cancer: A Multicenter, Open-Label, Phase I Trial
5天前
已完结
460PReal-world experience in Chinese myasthenia gravis patients receiving efgartigimod: a nationwide retrospective study
7天前
已关闭
Treat-to-Target Urate-Lowering Treatment and Cardiovascular Outcomes in Patients With Gout
8天前
已完结
Association of sustained lupus low disease activity state with improved outcomes in systemic lupus erythematosus: a multinational prospective cohort study
8天前
已完结
Gout: diagnosis and management—summary of NICE guidance
9天前
已完结
Psoriasis and risk of diabetic retinopathy in patients with type 2 diabetes mellitus
13天前
已完结
Efficacy and Safety of Aurantii Fructus Immaturus Flavonoid Tablets in Patients with Functional Dyspepsia: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Clinical Trial
13天前
已完结
The epidemiological landscape of multiple myeloma: a global cancer registry estimate of disease burden, risk factors, and temporal trends
14天前
已完结
The epidemiological landscape of multiple myeloma: a global cancer registry estimate of disease burden, risk factors, and temporal trends
14天前
已完结
Efficacy and safety benefits of HR17031 , a fixed‐ratio combination of INS068 and noiiglutide, versus its components alone in Chinese patients with type 2 diabetes uncontrolled on oral antidiabetic drug(s): A phase 2, multicentre, open‐label, randomised, parallel three‐arm, treat‐to‐target trial
15天前
已完结
皖公网安备34019202002308
